Free Access
The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta
Address correspondence and reprint requests to Horst H. Simon, Interdisciplinary Center for Neuroscience, Department of Neuroanatomy, University of Heidelberg, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany. E‐mail: horst.simon@urz.uni‐heidelberg.de
Abstract
Degeneration of dopaminergic neurons in the substantia nigra is associated with one of the most prominent human neurological disorders, Parkinson's disease. It is therefore of high interest to identify molecules with trophic effects on this neuronal population. We show here that the neuregulin receptor ErbB4 is differentially expressed in mesencephalic dopaminergic neurons, found in the substantia nigra and in a subregion of the ventral tegmentum but not in the retrorubral field. Early developmental onset and continued expression of ErbB4 into the adult and the presence of two high affinity ligands, neuregulin‐1 and betacellulin, in the basal ganglia, suggested that these molecules might participate in the differentiation and/or maintenance of the nigrostriatal system. In order to address this hypothesis, we used a loxP flanked ErbB4 allele in combination with a nestin‐Cre transgene and generated brain‐specific ErbB4 null mice. These mutant animals survived into adulthood. The distribution of dopaminergic cell bodies in the midbrain, the expression of numerous genes specific to mesencephalic dopaminergic neurons, and the axonal projection to the basal ganglia all appeared normal. Finally, an assessment of their motor function revealed no behavioral deficits. The apparent lack of any mutant phenotype suggests the presence of a strong compensatory mechanism.
Citing Literature
Number of times cited: 23
- Kani Shang, David A. Talmage and Tim Karl, Parent-of-origin effects on schizophrenia-relevant behaviours of type III neuregulin 1 mutant mice, Behavioural Brain Research, 332, (250), (2017).
- M Skirzewski, I Karavanova, A Shamir, L Erben, J Garcia-Olivares, J H Shin, D Vullhorst, V A Alvarez, S G Amara and A Buonanno, ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors, Molecular Psychiatry, (2017).
- Hisaaki Namba, Takeshi Okubo and Hiroyuki Nawa, Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling, Scientific Reports, 6, 1, (2016).
- Candan Depboylu, Thomas W. Rösler, Anderson Andrade, Wolfgang H. Oertel and Günter U. Höglinger, Systemically administered neuregulin‐1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease, Journal of Neurochemistry, 133, 4, (590-597), (2015).
- Paula M. Moran, Colm M.P. O'Tuathaigh, Francesco Papaleo and John L. Waddington, Dopaminergic function in relation to genes associated with risk for schizophrenia, Dopamine, 10.1016/B978-0-444-63425-2.00004-0, (79-112), (2014).
- Candan Depboylu, Matthias Höllerhage, Stefan Schnurrbusch, Patrik Brundin, Wolfgang H. Oertel, André Schrattenholz and Günter U. Höglinger, Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease, Neuroscience Letters, 531, 2, (209), (2012).
- T Kato, Y Abe, H Sotoyama, A Kakita, R Kominami, S Hirokawa, M Ozaki, H Takahashi and H Nawa, Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia, Molecular Psychiatry, 16, 3, (307), (2011).
- Lars Tönges, Thomas Ostendorf, Fabienne Lamballe, Matthieu Genestine, Rosanna Dono, Jan‐Christoph Koch, Mathias Bähr, Flavio Maina and Paul Lingor, Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo, Journal of Neurochemistry, 117, 5, (892-903), (2011).
- Thomas Carlsson, Friederike R. Schindler, Matthias Höllerhage, Candan Depboylu, Oscar Arias‐Carrión, Stefan Schnurrbusch, Thomas W. Rösler, Wojciech Wozny, Gerhard P. Schwall, Karlfried Groebe, Wolfgang H. Oertel, Patrik Brundin, André Schrattenholz and Günter U. Höglinger, Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease, Journal of Neurochemistry, 117, 6, (1066-1074), (2011).
- Thomas W. Rösler, Candan Depboylu, Oscar Arias-Carrión, Wojciech Wozny, Thomas Carlsson, Matthias Höllerhage, Wolfgang H. Oertel, André Schrattenholz and Günter U. Höglinger, Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1, Neuropharmacology, 61, 8, (1413), (2011).
- T. Karl, T.H.J. Burne, M. Van den Buuse and R. Chesworth, Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?, Behavioural Brain Research, 223, 2, (336), (2011).
- Anamika Banerjee, Mathew L. MacDonald, Karin E. Borgmann-Winter and Chang-Gyu Hahn, Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome, Brain Research Bulletin, 10.1016/j.brainresbull.2010.04.011, 83, 3-4, (132-139), (2010).
- M. van den Buuse, Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects, Schizophrenia Bulletin, 36, 2, (246), (2010).
- L. Wen, Y.-S. Lu, X.-H. Zhu, X.-M. Li, R.-S. Woo, Y.-J. Chen, D.-M. Yin, C. Lai, A. V. Terry, A. Vazdarjanova, W.-C. Xiong and L. Mei, Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons, Proceedings of the National Academy of Sciences, 10.1073/pnas.0910302107, 107, 3, (1211-1216), (2009).
- Yingjun Zheng, Akiya Watakabe, Masahiko Takada, Akiyoshi Kakita, Hisaaki Namba, Hitoshi Takahashi, Tetsuo Yamamori and Hiroyuki Nawa, Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 4, (701), (2009).
- J.W. Dickerson, A.M. Hemmerle, S. Numan, K.H. Lundgren and K.B. Seroogy, Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats, Neuroscience, 10.1016/j.neuroscience.2009.06.008, 163, 1, (482-489), (2009).
- Y. Abe, H. Namba, Y. Zheng and H. Nawa, In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: Implication of ErbB receptors for dopaminergic neurons, Neuroscience, 10.1016/j.neuroscience.2009.03.022, 161, 1, (95-110), (2009).
- Lin Mei and Wen-Cheng Xiong, Neuregulin 1 in neural development, synaptic plasticity and schizophrenia, Nature Reviews Neuroscience, 10.1038/nrn2392, 9, 6, (437-452), (2008).
- Mark J. Millan and Mauricette Brocco, Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138, Thérapie, 63, 3, (187), (2008).
- Colm M.P. O’Tuathaigh, Daniela Babovic, Gillian O’Meara, Jeremiah J. Clifford, David T. Croke and John L. Waddington, Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2006.04.002, 31, 1, (60-78), (2007).
- Marten P. Smidt and J. Peter H. Burbach, How to make a mesodiencephalic dopaminergic neuron, Nature Reviews Neuroscience, 10.1038/nrn2039, 8, 1, (21-32), (2007).
- Jesper Roland Jørgensen, Bengt Juliusson, Karen Friis Henriksen, Claus Hansen, Steen Knudsen, Thomas Nordahl Petersen, Nikolaj Blom, Åke Seiger and Lars U. Wahlberg, Identification of novel genes regulated in the developing human ventral mesencephalon, Experimental Neurology, 198, 2, (427), (2006).
- John J. Krolewski, Cytokine and growth factor receptors in the nucleus: What's up with that?, Journal of Cellular Biochemistry, 95, 3, (478-487), (2005).
